Company intelligence / Profile preview

ZoaDx

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

ZoaDx is a newly launched contract research organization (CRO) focused on translating animal health innovations—including diagnostics, therapeutics, and vaccines—through services encompassing clinical research, regulatory support, and quality assurance consulting for both companion and production animals. The company specializes in navigating complex regulatory pathways (e.g., FDA, USDA, CVB) for animal health products and has recently launched its services with multiple strategic partnerships but has not yet advanced its own programs to clinical or regulatory milestones.

Therapeutic areas: OtherInfectious Diseases
Modalities: BiologicVaccineSmall moleculeIn vitro diagnostic
Industry: Contract Research Organization

Partnerships

CovarsaDxClearDx Labs

Beyond the preview

Go deeper on ZoaDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZoaDx.

Explore the full profile